August 2019
- andreachicca797
- Aug 1, 2019
- 1 min read
Updated: Jan 8
Synendos receives a co-fund by the European Union as part of the SME Instrument phase 1 (Horizon2020) to contribute to the translation of our preclinical programme into clinical development.
